Literature DB >> 23645123

Gait and cognition in Parkinson's disease: implications for rehabilitation.

Robert Iansek1, Mary Danoudis, Nicholas Bradfield.   

Abstract

An increasing awareness of the interaction between gait and cognition has occurred over recent time. This interaction is even more prominent in Parkinson's disease (PD), where the alteration of striatal dopamine deficiency places a greater emphasis on cognition to compensate for the gait disturbances seen in PD. This dissertation aims to provide an insight into this interaction in PD and demonstrate how normal gait control mechanisms are altered in PD to more cognitive control. Evidence will be provided which demonstrates a shift between attention and automatic gait control mechanisms toward attention. In addition, it will be demonstrated that, because of the cognitive dysfunction that also occurs in PD, the capacity to normalize gait still remains impaired and becomes more subject to the effects of external environmental influences. Further, a rationale will be provided to utilize this interaction in a more beneficial manner, to assist the attention control mechanisms to return gait towards normal. This latter approach is applicable to all aspects of gait disorders in PD and forms a basis for possible intervention therapies.

Entities:  

Mesh:

Year:  2013        PMID: 23645123     DOI: 10.1515/revneuro-2013-0006

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  6 in total

1.  Gait performance and non-motor symptoms burden during dual-task condition in Parkinson's disease.

Authors:  Meimei Zhang; Yawen Gan; Xuemei Wang; Zhan Wang; Tao Feng; Yumei Zhang
Journal:  Neurol Sci       Date:  2022-09-20       Impact factor: 3.830

2.  Effects of motor imagery training of Parkinson's disease: a protocol for a randomized clinical trial.

Authors:  Isaíra Almeida Pereira da Silva Nascimento; Lorenna Marques de Melo Santiago; Aline Alves de Souza; Camila de Lima Pegado; Tatiana Souza Ribeiro; Ana Raquel Rodrigues Lindquist
Journal:  Trials       Date:  2019-11-09       Impact factor: 2.279

3.  Epalrestat improves motor symptoms by reducing oxidative stress and inflammation in the reserpine induced mouse model of Parkinson's disease.

Authors:  Md Mahbubur Rahman; Rupali Rani Chakraborti; Md Abdullah Potol; Ariful Haque Abir; Ozayra Sharmin; Mahabub Alam; Md Fazlur Rahman Khan; Rownock Afrin; Humayra Jannat; Rasiqh Wadud; Zaki Farhad Habib
Journal:  Animal Model Exp Med       Date:  2019-12-30

4.  Perception and Use of Compensation Strategies for Gait Impairment by Persons With Parkinson Disease.

Authors:  Anouk Tosserams; Lisanne Wit; Ingrid H W M Sturkenboom; Maarten J Nijkrake; Bastiaan R Bloem; Jorik Nonnekes
Journal:  Neurology       Date:  2021-09-08       Impact factor: 9.910

Review 5.  Gait, posture and cognition in Parkinson's disease.

Authors:  Alessandra Ferreira Barbosa; Janini Chen; Fernanda Freitag; Debora Valente; Carolina de Oliveira Souza; Mariana Callil Voos; Hsin Fen Chien
Journal:  Dement Neuropsychol       Date:  2016 Oct-Dec

6.  Motor-Cognitive Treadmill Training With Virtual Reality in Parkinson's Disease: The Effect of Training Duration.

Authors:  Elisa Pelosin; Chiara Ponte; Martina Putzolu; Giovanna Lagravinese; Jeffrey M Hausdorff; Alice Nieuwboer; Pieter Ginis; Lynn Rochester; Lisa Alcock; Bastiaan R Bloem; Freek Nieuwhof; Andrea Cereatti; Ugo Della Croce; Anat Mirelman; Laura Avanzino
Journal:  Front Aging Neurosci       Date:  2022-01-05       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.